These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37098074)

  • 1. Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
    Kaida T; Fujiyama Y; Soeno T; Yokota M; Nakamoto S; Goto T; Watanabe A; Okuno K; Nie Y; Fujino S; Yokota K; Harada H; Tanaka Y; Tanaka T; Yokoi K; Kojo K; Miura H; Yamanashi T; Sato T; Sasaki J; Sangai T; Hiki N; Kumamoto Y; Naitoh T; Yamashita K
    PLoS One; 2023; 18(4):e0277395. PubMed ID: 37098074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
    Sahlberg SH; Spiegelberg D; Glimelius B; Stenerlöw B; Nestor M
    PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis.
    Abbasian M; Mousavi E; Arab-Bafrani Z; Sahebkar A
    J Cell Physiol; 2019 Jun; 234(6):8192-8202. PubMed ID: 30317669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
    Pitule P; Cedikova M; Daum O; Vojtisek J; Vycital O; Hosek P; Treska V; Hes O; Kralickova M; Liska V
    Biomed Res Int; 2014; 2014():432139. PubMed ID: 24864242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Spelt L; Sasor A; Ansari D; Hilmersson KS; Andersson R
    Anticancer Res; 2018 Jan; 38(1):313-320. PubMed ID: 29277789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
    Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
    Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers.
    Chen J; Guo T; Zhang L; Qin LX; Singer S; Maki RG; Taguchi T; Dematteo R; Besmer P; Antonescu CR
    Genes Chromosomes Cancer; 2012 Feb; 51(2):186-95. PubMed ID: 22076958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-8/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133
    Ma X; Chen J; Liu J; Xu B; Liang X; Yang X; Feng Y; Liang X; Liu J
    J Cell Physiol; 2021 Apr; 236(4):3114-3128. PubMed ID: 33078417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133.
    Feitosa NPP; Pereira VBM; Silva BGB; Queroz AVF; Rodrigues BJ; Costa MLV; Alencar CH; Lima-Júnior RCP; Wong DVT; Frota CC; Almeida PRC
    Acta Histochem; 2021 Oct; 123(7):151787. PubMed ID: 34517259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.